AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy
Article in Journal of Translational Medicine (August 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
EGFLAM exhibits oncogenic activity and shows promise as a prognostic biomarker and therapeutic target in glioblastoma
Article in International Immunopharmacology (July 2024)
Elucidating B4GALNT1 as potential biomarker in hepatocellular carcinoma using machine learning models and mutational dynamics explored through MD simulation
Article in Informatics in Medicine Unlocked (January 2024)